U.S. Hospitality Stock News

NYSE:TFX
NYSE:TFXMedical Equipment

Assessing Teleflex (TFX) Valuation As Mixed Share Price Momentum Draws Fresh Investor Attention

Why Teleflex is Back on Investors’ Radar Teleflex (TFX) has attracted renewed attention after recent share price moves, with the stock up over the past month but lower over the past 3 months and year to date. See our latest analysis for Teleflex. Teleflex’s recent 1 month share price return of 1.94% sits against a weaker backdrop, with a 3 month share price return showing an 8.71% decline and a 1 year total shareholder return reflecting an 8.10% loss, suggesting momentum has been fading...
NasdaqGS:CRUS
NasdaqGS:CRUSSemiconductor

Stronger Q3 Results and Apple Manufacturing Role Could Be A Game Changer For Cirrus Logic (CRUS)

Cirrus Logic, Inc. recently disclosed that effective March 25, 2026, Chief Financial Officer Jeff Woolard also became Principal Accounting Officer, while former Principal Accounting Officer Ulf Habermann moved into a senior role within the finance team without any disagreement over company operations or policies. At the same time, Cirrus Logic’s stronger-than-expected fiscal third-quarter results and its role in Apple’s expanded American Manufacturing Program highlight both operational...
NasdaqCM:CLDX
NasdaqCM:CLDXBiotechs

A Look At Celldex Therapeutics (CLDX) Valuation After Equity Raise And New Barzolvolimab Data

Celldex Therapeutics (CLDX) recently closed a large underwritten public equity offering, raising about US$345 million soon after sharing new Phase 2 barzolvolimab data in multiple chronic urticaria indications at a major dermatology conference. See our latest analysis for Celldex Therapeutics. At a share price of US$31.35, Celldex has logged a 1 month share price return of 6.52% and a year to date share price return of 16.07%. The 1 year total shareholder return of 107.20% contrasts with a...
NasdaqGS:MORN
NasdaqGS:MORNCapital Markets

Morningstar (MORN) Valuation Check As Snowflake Partnership Expands Data And AI Workflow Role

Morningstar (MORN) caught fresh attention after expanding the availability of its investment data on Snowflake Marketplace, giving institutional clients broader access to indexes, ESG ratings, credit ratings, and analytics directly within Snowflake environments. See our latest analysis for Morningstar. Despite the Snowflake partnership and recent milestones at Morningstar DBRS, Morningstar’s 7 day share price return of 4.5% sits against a weaker backdrop, with a 30 day share price decline of...
NasdaqGS:IRTC
NasdaqGS:IRTCMedical Equipment

The Bull Case For iRhythm Holdings (IRTC) Could Change Following New Auditor And AI Zio Upgrade - Learn Why

In late March 2026, iRhythm Holdings replaced PricewaterhouseCoopers with KPMG as its independent auditor and unveiled extensive new clinical data, AI initiatives, and product enhancements for its Zio ambulatory ECG monitoring service at the American College of Cardiology 2026 meeting. The company’s use of billions of hours of curated heartbeat data to inform AI-driven arrhythmia risk prediction and clinician education underscores how deeply data and analytics are becoming embedded in its...
NasdaqGS:PFBC
NasdaqGS:PFBCBanks

Revenue Beat And “Top-Tier” Profitability Might Change The Case For Investing In Preferred Bank (PFBC)

Preferred Bank recently reported quarterly results showing revenue up 7.2% year on year, beating analyst estimates by 4.8%, while earnings per share matched expectations. Chairman and CEO Li Yu emphasized that the bank’s profitability sits in the top tier of the banking industry, underscoring the quality of its earnings rather than just their size. We’ll now examine how this revenue outperformance and management’s emphasis on top-tier profitability affect Preferred Bank’s existing investment...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

If You Believe In Transformative AI Healthcare Stocks Then This Trio Resets Your Horizon Trajectory

Artificial intelligence in healthcare is one of the clearest ways technology meets real world need, especially as higher energy prices, geopolitical tension, and sticky inflation keep pressure on costs and productivity. While many sectors face softer activity and rising input prices, AI tools that support better diagnostics, smoother hospital operations, and faster drug discovery speak directly to efficiency and outcomes. This screener focuses on companies applying AI to these problems,...
NYSE:BDX
NYSE:BDXMedical Equipment

Does BD’s New Connected Monitoring And Medication Tools Meaningfully Shift The Bull Case For BDX?

Becton, Dickinson and Company recently launched the HemoSphere Stream Module for continuous, noninvasive blood pressure monitoring and introduced the BD Pyxis Pro Dispensing Solution and BD Incada Connected Care Platform in Europe to modernize medication management and analytics. These launches highlight BD’s push into connected, data-rich hospital workflows, linking bedside monitoring with cloud-based medication insights across a broad installed base. We’ll now examine how BD’s expansion of...
NasdaqGS:MGNI
NasdaqGS:MGNIMedia

A Closer Look At Magnite (MGNI) Valuation After Recent Share Price Weakness

Magnite at a glance Magnite (MGNI) sits at the center of the sell side of digital advertising, connecting publishers and buyers across connected TV, apps, websites, and other media properties through its independent advertising platform. With revenue of US$713.953 million and net income of US$144.613 million, the company generates most of its sales in the United States. International operations add a meaningful secondary revenue stream. See our latest analysis for Magnite. Magnite’s share...
NasdaqGS:SBAC
NasdaqGS:SBACSpecialized REITs

A Look At SBA Communications (SBAC) Valuation After Recent Share Price Momentum

SBA Communications (SBAC) has drawn investor attention after recent share price moves, including a 3.1% one day decline and gains over the past week, month and past 3 months. These shifts highlight its focus as a tower-oriented REIT. See our latest analysis for SBA Communications. The recent 7 day share price return of 19.61% and 90 day share price return of 13.47% contrast with a 3 year total shareholder return of 17.45% and 5 year total shareholder return of 21.38% declines, suggesting...
NYSE:WHR
NYSE:WHRConsumer Durables

Should Whirlpool’s (WHR) Premium Kitchen Showcase in Toronto Matter for Its Long‑Term Strategy?

In April 2026, JennAir Canada and KitchenAid, both Whirlpool brands, showcased luxury and smart kitchen innovations at the Living Luxe Design Show in Toronto, highlighting products like downdraft induction cooktops, leather-clad refrigeration, and camera-enabled ovens in immersive boutique-style exhibits. This emphasis on high-end, customizable appliances and experiential branding underlines Whirlpool’s push toward premiumization and design-led differentiation in the competitive home...
NasdaqGS:CART
NasdaqGS:CARTConsumer Retailing

Assessing Maplebear (CART) Valuation After Instacart Becomes ALDI U.S. Fulfillment Partner

Maplebear (CART), parent of Instacart, is back in focus after ALDI U.S. rolled out a redesigned website and mobile app powered by Instacart’s Storefront Pro platform and fulfillment solutions. See our latest analysis for Maplebear. The ALDI Storefront Pro launch comes as momentum in Maplebear’s share price has been mixed, with a 7 day share price return of 9.77% and a 1 year total shareholder return of 10.78% around the recent US$41.12 level. If this Instacart and ALDI partnership has you...
NasdaqGS:GEN
NasdaqGS:GENSoftware

Is Gen Digital (GEN) Offering An Opportunity After Recent Share Price Weakness

If you are wondering whether Gen Digital is priced attractively right now, or if the recent volatility is a warning sign, this article focuses squarely on what the current share price might be implying. Over the short term, the stock has recent returns of 1.9% over 7 days, a 15.2% decline over 30 days, a 26.4% decline year to date, a 16.9% decline over 1 year, a 14.9% gain over 3 years, and a 1.2% decline over 5 years. Together, these figures give you a mixed picture of how sentiment has...
NasdaqGM:LNTH
NasdaqGM:LNTHMedical Equipment

Assessing Lantheus Holdings (LNTH) Valuation After Recent Share Price Momentum

Event context and recent performance Lantheus Holdings (LNTH) has drawn fresh attention after its recent trading performance, with the stock up about 3% over the past week, 8% over the past month, and 13% in the past 3 months. See our latest analysis for Lantheus Holdings. At a share price of $78.08, Lantheus has seen short term momentum build with a 30 day share price return of 7.61% and year to date share price return of 16.07%. However, the 1 year total shareholder return of 16.41% and 3...
NasdaqGS:ASO
NasdaqGS:ASOSpecialty Retail

Is It Time To Reassess Academy Sports and Outdoors (ASO) After Its Strong 1 Year Rally?

If you are wondering whether Academy Sports and Outdoors is attractively priced right now, the stock's recent track record and current valuation metrics offer a useful starting point for your own view. The share price closed at US$57.18 recently, with returns of 1.3% over 7 days, a 5.1% decline over 30 days, 9.6% year to date, 69.5% over 1 year, a 11.0% decline over 3 years, and 86.9% over 5 years. This gives you a range of outcomes to weigh. Recent coverage of Academy Sports and Outdoors...
NYSE:LLY
NYSE:LLYPharmaceuticals

Is It Time To Reassess Eli Lilly (LLY) After GLP‑1 Obesity Drug Breakthroughs?

If you are wondering whether Eli Lilly's current share price fairly reflects its potential, you are not alone. This article will help you frame that question in a structured way. At a last close of US$931.09, the stock has seen a 1.2% gain over the past 7 days, a 6.0% decline over 30 days, a 13.8% decline year to date, a 29.2% return over the past year and a very large gain over 5 years. Recent news around Eli Lilly has focused heavily on its role in high profile therapeutic areas, including...
NasdaqGS:CACC
NasdaqGS:CACCConsumer Finance

Is Credit Acceptance (CACC) Price Justified After Recent Share Rebound And Mixed Valuation Signals

If you are trying to work out whether Credit Acceptance at around US$444 per share looks expensive or offers value, the starting point is understanding what the current share price actually reflects. Over the last week the stock is up 5.0%, while the 1 year return sits at a 5.0% decline and the year to date move is a 2.0% decline, which hints that sentiment around risk and reward has shifted more than once recently. The share price moves sit against a backdrop of ongoing attention on...
NYSE:SPCE
NYSE:SPCEAerospace & Defense

Assessing Virgin Galactic (SPCE) Valuation After Fresh Analyst Outlooks And 2025 Financial Results

Why Virgin Galactic’s latest filings and results are drawing attention Virgin Galactic Holdings (SPCE) has come back into focus after its fourth quarter and full year 2025 results, alongside a new shelf registration for common stock tied to an employee stock ownership plan. The company reported fourth quarter 2025 sales of US$0.312 million and a net loss of US$62.72 million, with full year sales of US$1.54 million and a net loss of US$278.91 million, prompting fresh interest in its capital...
NYSE:ACHR
NYSE:ACHRAerospace & Defense

Is Archer Aviation (ACHR) Offering Opportunity After Recent Share Price Swings And DCF Estimate

Wondering whether Archer Aviation at around US$5.34 is offering value or just volatility? This breakdown is designed to help you weigh what the current price might really reflect. The stock has had a mixed run, with a 3.3% gain over the last 7 days, a 14.7% decline over 30 days, a 34.3% decline year to date, and a 16.6% decline over the past year, alongside a 100.8% return across 3 years and a 46.9% decline over 5 years. These swings sit against a backdrop where investors are closely...
NYSE:DLB
NYSE:DLBSoftware

Assessing Dolby Laboratories (DLB) Valuation After Recent Share Price Pullback

Why Dolby Laboratories Stock Is Drawing Fresh Attention Dolby Laboratories (DLB) is back on investors’ radar after a recent share price slide over the past month and past 3 months, prompting closer scrutiny of its current valuation and fundamentals. See our latest analysis for Dolby Laboratories. At the latest share price of $61.2, Dolby’s recent 30 day share price return of 6.26% and one year total shareholder return of 10.01% suggest momentum has been fading rather than building, which...
NYSE:WCC
NYSE:WCCTrade Distributors

Is It Too Late To Consider WESCO International (WCC) After A 111% One-Year Surge?

If you are wondering whether WESCO International's share price still offers value, or if the easier gains have already been made, this article breaks down what the current price might be implying. The stock most recently closed at US$278.57, with returns of 1.8% over 7 days, 5.5% over 30 days, 10.5% year to date, 111.4% over 1 year, 110.0% over 3 years, and 232.4% over 5 years. Recent market attention around WESCO International has focused on its role as a key distributor in capital goods...
NYSE:PFE
NYSE:PFEPharmaceuticals

Belgian Court Ruling Extends Pfizer Covid Cash Flow And Legal Questions

Belgian court orders Poland and Romania to honor multi billion euro COVID 19 vaccine contracts with Pfizer/BioNTech. Ruling requires the countries to take delivery of and pay for contracted vaccine volumes despite their objections. Decision highlights the enforceability of pandemic era procurement deals for vaccine makers such as NYSE:PFE. For investors watching NYSE:PFE, this ruling adds a legal and contractual angle to a stock that last closed at $27.1. The company shows mixed long term...
NasdaqGS:DRS
NasdaqGS:DRSAerospace & Defense

Is It Too Late To Consider Leonardo DRS (DRS) After Its Strong 48% One-Year Rally?

If you are wondering whether Leonardo DRS at US$46.19 still offers value or if most of the opportunity is already priced in, the next sections break down what the current share price might be implying. The stock has returned 3.8% over the last 7 days, is flat over the past month with a 0.8% decline, and sits on 32.8% year to date and 48.3% over the last year. This sets the scene for a closer look at what investors may be paying for today. Recent coverage has focused on Leonardo DRS as a key...
NYSE:STT
NYSE:STTCapital Markets

Did BofA Upgrade and New Accounting Chief Just Reframe State Street's (STT) Governance Narrative?

State Street Corporation has appointed C. Jack Read as Executive Vice President, Global Controller and Chief Accounting Officer, effective August 10, 2026, succeeding Elizabeth M. Schaefer. Read’s long track record in senior finance and risk roles across major banks and an index provider may influence how State Street manages financial reporting, controls, and regulatory complexity. We’ll now examine how B of A Securities’ rating upgrade and the incoming chief accounting officer could shape...